Advertisement
Cyberattacks remain a serious threat to small providers as well as big institutions

Cyberattacks Remain Serious Threat to Health Providers

0
Processes, technology should be boosted against cyberthreats, which are becoming more sophisticated
Forty-four percent of U.S. adults are worried about having their personal health care information stolen

Health Information Theft a Pressing Concern for U.S. Patients

0
44 percent of U.S. adults are worried about having their personal health care information stolen
An internet-delivered physical therapist-prescribed home exercise and pain-coping skills training intervention is beneficial for individuals with chronic knee pain

Internet-Delivered Exercise, Pain-Coping Skills Alleviate Knee Pain

0
Clinically meaningful improvements in pain, function with home exercise and pain-coping skills training
The U.S. Centers for Medicare & Medicaid Services has proposed a rule in relation to new reforms intended to stabilize individual and small group health insurance markets for 2018.

CMS Rule Set to Stabilize Small Health Insurance Markets

0
Rule includes special enrollment period pre-enrollment verification, flexibility in level of cover
In a case report published online Feb. 12 in the Journal of Clinical Pharmacy and Therapeutics

Drug-Induced Lupus Seen With Adalimumab Treatment

0
Patient with psoriasis developed muscle pain with paresthesia, ANA titer elevation with adalimumab
For patients with rheumatoid arthritis who have had an inadequate response to methotrexate

Baricitinib Associated With Significant Improvement in RA

0
Findings versus placebo, adalimumab in patients non-responsive to methotrexate
In patients with systemic lupus erythematosus

Research Suggests Potential Key to Alternative Lupus Treatment

0
Cells expressing MAVS-C79F variant have reduced ROS-dependent MAVS oligomerization in plasma
Health care spending is expected to grow at an average annual rate of 5.6 percent from 2016 to 2025

Health Care Spending Expected to Grow 5.6% Annually to 2025

0
National health expenditures expected to represent 19.9 percent of gross domestic product by 2025
The injected drug Siliq (brodalumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe plaque psoriasis in adults.

FDA Approves Siliq for Plaque Psoriasis

0
Injected medication approved for use by patients who've failed other treatments
About half of patients with chronic plaque psoriasis have fatigue

Fatigue Occurs in ~50 Percent With Chronic Plaque Psoriasis

0
Objective measures of psoriasis disease activity are not associated with fatigue severity